Home › Trial NCT04297202
SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular Carcinoma
- Trial IDNCT04297202
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorThe First Affiliated Hospital with Nanjing Medical University
- Enrollment20
- Start date2019-12-01
- ConditionsHepatocellular Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.